Heart diastolic dysfunction in patients with systemic sclerosis

Archives of Medical Science

Volumn 10, Issue 3, 2014, Pages 445-454

  Ciurzynski, Michal ^a   Bienias, Piotr ^a   Irzyk, Katarzyna ^a   Kostrubiec, Maciej ^a   Szewczyk, Agnieszka ^a   Demkow, Urszula ^a   Siwicka, Maria ^a   Kurnicka, Katarzyna ^a   Lichodziejewska, Barbara ^a   Pruszczyk, Piotr ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Biomarkers; Diastolic function; Echocardiography; Systemic sclerosis

Indexed keywords

BIOLOGICAL MARKER; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE RELAXATION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84903556193     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.43739     Document Type: Article

References (36)

1. Meune C, Avouac J, Wahbi K, et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 2008; 58: 1803-9.
2. Dziankowska-Bartkowiak B, Gerlicz-Kowalczuk Z, Waszczykowska E. Angiogenin and SDF-1alpha serum concentration in patients with systemic sclerosis in relation to clinical status. Arch Med Sci 2011; 7: 92-6.
3. Blaise S, Maas R, Trocme C, et al. Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis. J Rheumatol 2009; 36: 984-8.
4. Toubi E, Kessel A, Grushko G, Sabo E, Rozenbaum M, Rosner I. The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity. Clin Exp Rheumatol 2002; 20: 221-4.
5. Young-Min SA, Beeton C, Laughton R, et al. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001; 60: 846-51.
6. Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K. Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 1995; 33: 973-8.
7. Kim WU, Min SY, Cho ML, et al. Elevated matrix metalloproteinase- 9 in patients with systemic sclerosis. Arthritis Res Ther 2005; 7: R71-9.
8. Young-Min SA, Beeton C, Laughton R, et al. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001; 60: 846-51.
9. Hinchcliff M, Desai CS, Varga J, Shah SJ. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol 2012; 30 (2 Suppl 71): S30-7.
10. de Groote P, Gressin V, Hachulla E, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 31-6.
11. Giunta A, Tirri E, Maione S, et al. Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis 2000; 59: 94-8.
12. Kazzam E, Waldenstrom A, Landelius J, Hallgren R, Arvidsson A, Caidahl K. Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis. J Intern Med 1990; 228: 183-92.
13. Maione S, Valentini G, Giunta A, et al. Evaluation of cardiac structures and function in systemic sclerosis by Doppler echocardiography. Cardiology 1991; 79: 165-71.
14. Poanta L, Dadu R, Tiboc C, Rednic S, Dumitrascu D. Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med 2009; 20: 378-82.
15. Maione S, Cuomo G, Giunta A, et al. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 2005; 34: 721-7.
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
17. Valentini G, Bencivelli W, Bombardieri S, et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003; 62: 901-3.
18. Feigenbaum H, Armstrong WF, Ryan T. Feigenbaum's echocardiography. 6 ed. Lippincott, Williams & Wilkins, Philadelphia 2005.
19. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.
20. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-537.
21. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-93.
22. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-66.
23. Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996; 9: 838-47.
24. Hachulla AL, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009; 68: 1878-84.
25. Karatzis EN, Giannakopoulou AT, Papadakis JE, Karazachos AV, Nearchou NS. Myocardial performance index (Tei index): evaluating its application to myocardial infarction. Hellenic J Cardiol 2009; 50: 60-5.
26. Lacorte JC, Cabreriza SE, Rabkin DG, et al. Correlation of the Tei index with invasive measurements of ventricular function in a porcine model. J Am Soc Echocardiogr 2003; 16: 442-7.
27. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10: 169-78.
28. Lindqvist P, Caidahl K, Neuman-Andersen G, et al. Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study. Chest 2005; 128: 755-63.
29. Sebbag I, Rudski LG, Therrien J, Hirsch A, Langleben D. Effect of chronic infusion of epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary pulmonary hypertension. Am J Cardiol 2001; 88: 1060-3.
30. Ivanovic BA, Tadic MV, Zlatanovic MM, Damjanov NN, Ostojic PM, Bonaci-Nikolic BN. Which factors impact myocardial function in systemic sclerosis? Echocardiography 2012; 29: 307-17.
31. Terpstra WF, May JF, Smit AJ, et al. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial. J Hypertens 2001; 19: 303-9.
32. Young-Min SA, Beeton C, Laughton R, et al. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001; 60: 846-51.
33. Stakos DA, Tziakas DN, Chalikias GK, Mitrousi K, Tsigalou C, Boudoulas H. Associations between collagen synthesis and degradation and aortic function in arterial hypertension. Am J Hypertens 2010; 23: 488-94.
34. Zureik M, Beaudeux JL, Courbon D, Benetos A, Ducimetiere P. Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness. J Hypertens 2005; 23: 2263-8.
35. Shahin A, Elsawaf A, Ramadan S, Shaker O, Amin M, Taha M. Serum levels of tissue inhibitors of metalloproteinase 2 in patients with systemic sclerosis with duration more than 2 years: correlation with cardiac and pulmonary abnormalities. Mediators Inflamm 2006; 2006: 38458.
36. Jurisic Z, Martinovic-Kaliterna D, Marasovic-Krstulovic D, et al. Relationship between interleukin-6 and cardiac involvement in systemic sclerosis. Rheumatology (Oxford) 2013; 52: 1298-302.